Pfizer Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2006 | — | — | $1.83B |
| Dec 2007 | — | — | $3.41B |
| Jun 2008 | — | — | $820.0M |
| Sep 2008 | — | — | $1.27B |
| Dec 2008 | $53.41B | $111.15B | $2.12B |
| Mar 2009 | — | — | $1.25B |
| Jun 2009 | $76.10B | $139.34B | $2.24B |
| Sep 2009 | $75.04B | $141.29B | $4.23B |
| Dec 2009 | $122.50B | $212.95B | $1.98B |
| Jan 2010 | — | — | $1.98B |
| Apr 2010 | $105.03B | $195.11B | $1.76B |
| Jul 2010 | $104.19B | $191.07B | $1.88B |
| Oct 2010 | $103.35B | $191.42B | $2.18B |
| Dec 2010 | $106.75B | $195.01B | $1.74B |
| Apr 2011 | $104.42B | $194.96B | $730.0M |
| Jul 2011 | $106.94B | $195.90B | $3.10B |
| Oct 2011 | $105.60B | $196.13B | $3.71B |
| Dec 2011 | $105.38B | $188.00B | $3.18B |
| Apr 2012 | $102.01B | $185.68B | $2.93B |
| Jul 2012 | $102.88B | $182.84B | $3.03B |
| Sep 2012 | $100.49B | $182.60B | $4.51B |
| Dec 2012 | $104.12B | $185.80B | $10.08B |
| Mar 2013 | $104.57B | $187.40B | $1.89B |
| Jun 2013 | $100.36B | $179.34B | $2.44B |
| Sep 2013 | $97.17B | $175.52B | $2.05B |
| Dec 2013 | $95.48B | $172.10B | $2.18B |
| Mar 2014 | $93.74B | $171.81B | $2.86B |
| Jun 2014 | $95.66B | $172.61B | $3.41B |
| Sep 2014 | $93.06B | $171.36B | $2.44B |
| Dec 2014 | $95.94B | $167.57B | $3.34B |
| Mar 2015 | $93.05B | $160.64B | $3.56B |
| Jun 2015 | $93.70B | $160.88B | $3.67B |
| Sep 2015 | $103.74B | $170.87B | $3.10B |
| Dec 2015 | $102.38B | $167.38B | $3.64B |
| Apr 2016 | $99.58B | $162.93B | $2.56B |
| Jul 2016 | $107.59B | $170.66B | $3.41B |
| Oct 2016 | $114.83B | $178.43B | $2.09B |
| Dec 2016 | $111.78B | $171.62B | $2.60B |
| Apr 2017 | $110.04B | $168.78B | $4.06B |
| Jul 2017 | $109.86B | $168.56B | $2.59B |
| Oct 2017 | $111.04B | $172.15B | $2.78B |
| Dec 2017 | $100.14B | $171.80B | $1.34B |
| Apr 2018 | $94.07B | $164.61B | $2.30B |
| Jul 2018 | $94.86B | $164.98B | $2.70B |
| Sep 2018 | $96.17B | $167.84B | $3.56B |
| Dec 2018 | $95.66B | $159.42B | $1.14B |
| Mar 2019 | $96.26B | $155.42B | $1.94B |
| Jun 2019 | $96.27B | $156.20B | $1.78B |
| Sep 2019 | $105.05B | $170.45B | $2.79B |
| Dec 2019 | $104.15B | $167.59B | $1.12B |
| Mar 2020 | $101.00B | $166.34B | $2.15B |
| Jun 2020 | $113.37B | $177.93B | $1.80B |
| Sep 2020 | $113.49B | $178.98B | $1.59B |
| Dec 2020 | $90.76B | $154.23B | $1.79B |
| Apr 2021 | $89.95B | $158.82B | $1.77B |
| Jul 2021 | $99.61B | $169.92B | $2.37B |
| Oct 2021 | $103.22B | $179.19B | $1.97B |
| Dec 2021 | $104.01B | $181.48B | $1.94B |
| Apr 2022 | $101.16B | $183.84B | $2.47B |
| Jul 2022 | $107.82B | $195.29B | $1.78B |
| Oct 2022 | $102.46B | $195.35B | $1.30B |
| Dec 2022 | $101.29B | $197.21B | $416.0M |
| Apr 2023 | $94.38B | $195.62B | $2.17B |
| Jul 2023 | $120.88B | $220.17B | $2.63B |
| Oct 2023 | $117.82B | $215.02B | $3.15B |
| Dec 2023 | $137.21B | $226.50B | $2.85B |
| Mar 2024 | $128.54B | $221.10B | $719.0M |
| Jun 2024 | $128.22B | $216.19B | $1.05B |
| Sep 2024 | $126.92B | $219.48B | $1.09B |
| Dec 2024 | $124.90B | $213.40B | $1.04B |
| Mar 2025 | $117.39B | $208.03B | $1.43B |
| Jun 2025 | $117.08B | $206.10B | $1.64B |
| Sep 2025 | $115.64B | $208.73B | $1.34B |
| Dec 2025 | $121.39B | $208.16B | $1.14B |
| Mar 2026 | $117.21B | $207.62B | $1.70B |
| Jun 2026 | $115.64B | $201.13B | $976.0M |